Charles S. Ryan, President of Quince Therapeutics QNCX, has filed 1 purchase and 0 sales on the open market. The latest trade was on 01/23.

CR

CR

Charles S. Ryan

President

Company

Quince Therapeutics QNCX

First filing

23/09/06

Trades

7 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

01/23

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Quince TherapeuticsQNCX	Open-market buy	24/08/20	24/08/22	48,387 sh	$0.65	$31,451.55	+65.3%